The Phase 1 trial is an open label, dose ranging clinical study designed to evaluate Vaxart’s second-generation oral norovirus vaccine constructs head-to-head against its first-generation constructs.

By Victoria Mejicanos, March 11, 2025 A recent post on Cal Poly Pomona’s subreddit page sparked a conversation about student involvement in the rebranding initiative after highlighting similar ...